The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exocrine Pancreatic Insufficiency Market Research Report 2024
Synopsis
Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
The global Exocrine Pancreatic Insufficiency market was valued at US$ 2015.4 million in 2023 and is anticipated to reach US$ 2644.6 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
This report aims to provide a comprehensive presentation of the global market for Exocrine Pancreatic Insufficiency, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exocrine Pancreatic Insufficiency.
Report Scope
The Exocrine Pancreatic Insufficiency market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exocrine Pancreatic Insufficiency market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exocrine Pancreatic Insufficiency companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
Segment by Type
Therapeutics
Diagnostics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exocrine Pancreatic Insufficiency companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
The global Exocrine Pancreatic Insufficiency market was valued at US$ 2015.4 million in 2023 and is anticipated to reach US$ 2644.6 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
This report aims to provide a comprehensive presentation of the global market for Exocrine Pancreatic Insufficiency, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exocrine Pancreatic Insufficiency.
Report Scope
The Exocrine Pancreatic Insufficiency market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exocrine Pancreatic Insufficiency market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exocrine Pancreatic Insufficiency companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
Segment by Type
Therapeutics
Diagnostics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exocrine Pancreatic Insufficiency companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Therapeutics
1.2.3 Diagnostics
1.3 Market by Application
1.3.1 Global Exocrine Pancreatic Insufficiency Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exocrine Pancreatic Insufficiency Market Perspective (2019-2030)
2.2 Exocrine Pancreatic Insufficiency Growth Trends by Region
2.2.1 Global Exocrine Pancreatic Insufficiency Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exocrine Pancreatic Insufficiency Historic Market Size by Region (2019-2024)
2.2.3 Exocrine Pancreatic Insufficiency Forecasted Market Size by Region (2025-2030)
2.3 Exocrine Pancreatic Insufficiency Market Dynamics
2.3.1 Exocrine Pancreatic Insufficiency Industry Trends
2.3.2 Exocrine Pancreatic Insufficiency Market Drivers
2.3.3 Exocrine Pancreatic Insufficiency Market Challenges
2.3.4 Exocrine Pancreatic Insufficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue
3.1.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue (2019-2024)
3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Players (2019-2024)
3.2 Global Exocrine Pancreatic Insufficiency Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exocrine Pancreatic Insufficiency Revenue
3.4 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio
3.4.1 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exocrine Pancreatic Insufficiency Revenue in 2023
3.5 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
3.6 Key Players Exocrine Pancreatic Insufficiency Product Solution and Service
3.7 Date of Enter into Exocrine Pancreatic Insufficiency Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exocrine Pancreatic Insufficiency Breakdown Data by Type
4.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Type (2019-2024)
4.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Type (2025-2030)
5 Exocrine Pancreatic Insufficiency Breakdown Data by Application
5.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Application (2019-2024)
5.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exocrine Pancreatic Insufficiency Market Size (2019-2030)
6.2 North America Exocrine Pancreatic Insufficiency Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exocrine Pancreatic Insufficiency Market Size by Country (2019-2024)
6.4 North America Exocrine Pancreatic Insufficiency Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exocrine Pancreatic Insufficiency Market Size (2019-2030)
7.2 Europe Exocrine Pancreatic Insufficiency Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2019-2024)
7.4 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size (2019-2030)
8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2019-2024)
8.4 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exocrine Pancreatic Insufficiency Market Size (2019-2030)
9.2 Latin America Exocrine Pancreatic Insufficiency Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2019-2024)
9.4 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size (2019-2030)
10.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2019-2024)
10.4 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Axcan Pharma
11.1.1 Axcan Pharma Company Detail
11.1.2 Axcan Pharma Business Overview
11.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Introduction
11.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.1.5 Axcan Pharma Recent Development
11.2 Aptalis Pharma
11.2.1 Aptalis Pharma Company Detail
11.2.2 Aptalis Pharma Business Overview
11.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Introduction
11.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.2.5 Aptalis Pharma Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Introduction
11.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Cilian
11.4.1 Cilian Company Detail
11.4.2 Cilian Business Overview
11.4.3 Cilian Exocrine Pancreatic Insufficiency Introduction
11.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.4.5 Cilian Recent Development
11.5 Nordmark Arzneimittel
11.5.1 Nordmark Arzneimittel Company Detail
11.5.2 Nordmark Arzneimittel Business Overview
11.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Introduction
11.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.5.5 Nordmark Arzneimittel Recent Development
11.6 Laboratoires Mayoly Spindler
11.6.1 Laboratoires Mayoly Spindler Company Detail
11.6.2 Laboratoires Mayoly Spindler Business Overview
11.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Introduction
11.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2019-2024)
11.6.5 Laboratoires Mayoly Spindler Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
